Business
WELL HEALTH COMPLETES $34.5 MILLION BOUGHT DEAL OFFERING OF COMMON SHARES
WELL HEALTH COMPLETES $34.5 MILLION BOUGHT DEAL OFFERING OF COMMON SHARES Canad...
About this update from Well Health Technologies Corp.
[{"type":"text","content":"\n \n \n \n WELL HEALTH COMPLETES $34.5 MILLION BOUGHT DEAL OFFERING OF COMMON SHARES\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN\n \n CANADA\n \n ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO\n \n UNITED STATES\n \n NEWSWIRE SERVICES OR DISSEMINATION IN\n \n THE UNITED STATES\n \n ./\n \n \n \n \n \n VANCOUVER, BC\n \n \n ,\n \n \n May 19, 2022\n \n \n /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (OTCMKTS: WHTCF) (\"\n \n WELL\n \n \" or the \"\n \n Company\n \n \") is pleased to announce that, further to its new release dated\n \n May 11, 2022\n \n , it has completed its previously announced bought deal public offering of 9,327,765 common shares in the capital of the Company (each, a \"\n \n Share\n \n \"), including 1,216,665 Shares issued pursuant to the over-allotment option which was exercised in full, at a price of\n \n $3.70\n \n per Share, for gross proceeds of approximately\n \n $34,512,731\n \n (the \"\n \n Offering\n \n \").\n \n \n \n \n \n \n \n \n \n \n Hamed Shahbazi\n \n , Chairman and CEO of WELL, commented, \"We had a very successful offering given the quality of the investors that we were able to attract at this crucial time.  The offering was led by one of the largest sovereign wealth funds in the world along with Mr.\n \n Li Ka\n \n -shing and included other high quality and award winning institutional and pension funds.  This offering allows WELL to improve its defensive and offensive posture at a critical time and will be deployed in a highly accretive manner that definitively generates shareholder value.  We thank all those who participated and facilitated this offering for their support.\"\n \n \n The Company intends to use the net proceeds of the Offering to fund growth initiatives, including potential future acquisitions in the areas of physician acquisition, higher margin speciality clinics and executive health opportunities, and for working capital and general corporate purposes.\n \n \n Eight Capital and Stifel GMP ac...